FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023043635> ?p ?o ?g. }

• W2023043635 endingPage "1370" @default.
• W2023043635 startingPage "1362" @default.
• W2023043635 abstract "Summary: Purpose: Some evidence suggests that levetiracetam (LEV) possesses antiepileptogenic characteristics. The purpose of this study was to investigate the time course of seizure protection by LEV compared with that of phenytoin (PHT), phenobarbital (PB), valproate (VPA), and carbamazepine (CBZ) in the spontaneously epileptic rat (SER). The SER is a double mutant ( tm/tm , zi/zi ) showing both tonic convulsions and absence‐like seizures. Methods: The effect of single (40, 80, and 160 mg/kg, i.p.) and 5‐day (80 mg/kg/day, i.p.) administration of LEV on tonic convulsions and absence‐like seizures in SERs were studied. Tonic convulsions induced by blowing air onto the animal's head at 5‐min intervals for 30 min and spontaneous absence‐like seizures characterized by 5‐ to 7‐Hz spike–wave‐like complexes in the cortical and hippocampal EEG were recorded for 30 min. In the single‐administration study, observations for seizure activity were performed once before and 3 times (45, 75, and 135 min) after drug administration. In the 5‐day administration study, seizure observation was performed 4 times for 30 min (once before and 3 times after drug administration) during the 5‐day drug‐administration period, and continued once a day until 8 days after the final administration. The antiepileptic effects of 5‐day administration of conventional AEDs (PHT, PB, VPA, and CBZ) were examined by using similar methods. Results: Tonic convulsions and absence‐like seizures were inhibited by a single administration of LEV at 80 and 160 mg/kg, i.p., but not significantly at 40 mg/kg, i.p. When LEV was repeatedly administered at 80 mg/kg/day, i.p., for 5 days to SERs, the inhibitory effects on seizures increased with administration time. The number of tonic convulsions and absence‐like seizures were significantly reduced to 39.1% and 38.4% compared with previous values, respectively, after 5‐day LEV administration. Furthermore, significant inhibition of tonic convulsions was detected ≤3 days after the final administration, and significant inhibition of absence‐like seizures was still observed 8 days after the final injection of LEV. This demonstrates long‐lasting seizure protection by LEV after cessation of treatment. PHT, PB, VPA, and CBZ inhibited tonic convulsions more potently compared with LEV in SERs. The maximal antiseizure effects of these drugs were reached after the initial administration, with almost the same antiseizure effects observed through day 5, despite continued drug administration. Moreover, a long‐lasting treatment effect was not observed with any of these drugs except for PHT and CBZ, both of which showed moderately prolonged antiseizure effects. Conclusions: These results show that LEV is effective in the treatment of both convulsive and absence‐like seizures in SERs after single‐ and multiple‐dose administration. Interestingly, in the 5‐day administration study, it was found that the antiepileptic effects for tonic convulsions and absence‐like seizures were observed both during the drug‐administration period and ≤8 days after the final administration of LEV. This long‐lasting effect suggests that LEV may possess an antiepileptogenic effect that it does not share with PHT, PB, VPA, and CBZ." @default.
• W2023043635 created "2016-06-24" @default.
• W2023043635 creator A5033038556 @default.
• W2023043635 creator A5070273099 @default.
• W2023043635 creator A5075273574 @default.
• W2023043635 creator A5084151540 @default.
• W2023043635 creator A5084968437 @default.
• W2023043635 date "2005-09-01" @default.
• W2023043635 modified "2023-10-13" @default.
• W2023043635 title "Long-lasting Antiepileptic Effects of Levetiracetam against Epileptic Seizures in the Spontaneously Epileptic Rat (SER): Differentiation of Levetiracetam from Conventional Antiepileptic Drugs" @default.
• W2023043635 cites W105915516 @default.
• W2023043635 cites W1504181864 @default.
• W2023043635 cites W1931450301 @default.
• W2023043635 cites W1966224996 @default.
• W2023043635 cites W1975555279 @default.
• W2023043635 cites W1979558709 @default.
• W2023043635 cites W1981294852 @default.
• W2023043635 cites W1984460952 @default.
• W2023043635 cites W1986651096 @default.
• W2023043635 cites W1987343218 @default.
• W2023043635 cites W1988669795 @default.
• W2023043635 cites W1990370429 @default.
• W2023043635 cites W1992018126 @default.
• W2023043635 cites W1996135664 @default.
• W2023043635 cites W1997309303 @default.
• W2023043635 cites W1998832136 @default.
• W2023043635 cites W2001730079 @default.
• W2023043635 cites W2006516773 @default.
• W2023043635 cites W2009502669 @default.
• W2023043635 cites W2011652334 @default.
• W2023043635 cites W2011785379 @default.
• W2023043635 cites W2013224345 @default.
• W2023043635 cites W2020874899 @default.
• W2023043635 cites W2022919161 @default.
• W2023043635 cites W2025490080 @default.
• W2023043635 cites W2029085177 @default.
• W2023043635 cites W2034298437 @default.
• W2023043635 cites W2035439734 @default.
• W2023043635 cites W2036295400 @default.
• W2023043635 cites W2037641488 @default.
• W2023043635 cites W2038552386 @default.
• W2023043635 cites W2039779597 @default.
• W2023043635 cites W2046505029 @default.
• W2023043635 cites W2048986915 @default.
• W2023043635 cites W2049757067 @default.
• W2023043635 cites W2049802977 @default.
• W2023043635 cites W2057802344 @default.
• W2023043635 cites W2074901704 @default.
• W2023043635 cites W2075574360 @default.
• W2023043635 cites W2076021110 @default.
• W2023043635 cites W2087243332 @default.
• W2023043635 cites W2093083388 @default.
• W2023043635 cites W2095861076 @default.
• W2023043635 cites W2096990903 @default.
• W2023043635 cites W2097545500 @default.
• W2023043635 cites W2099226787 @default.
• W2023043635 cites W2100894520 @default.
• W2023043635 cites W2100990673 @default.
• W2023043635 cites W2115177619 @default.
• W2023043635 cites W2122573606 @default.
• W2023043635 cites W2127801604 @default.
• W2023043635 cites W2147839245 @default.
• W2023043635 cites W2156522224 @default.
• W2023043635 cites W2168143783 @default.
• W2023043635 cites W2443857821 @default.
• W2023043635 doi "https://doi.org/10.1111/j.1528-1167.2005.29604.x" @default.
• W2023043635 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16146430" @default.
• W2023043635 hasPublicationYear "2005" @default.
• W2023043635 type Work @default.
• W2023043635 sameAs 2023043635 @default.
• W2023043635 citedByCount "51" @default.
• W2023043635 countsByYear W20230436352012 @default.
• W2023043635 countsByYear W20230436352013 @default.
• W2023043635 countsByYear W20230436352014 @default.
• W2023043635 countsByYear W20230436352015 @default.
• W2023043635 countsByYear W20230436352016 @default.
• W2023043635 countsByYear W20230436352017 @default.
• W2023043635 countsByYear W20230436352018 @default.
• W2023043635 countsByYear W20230436352019 @default.
• W2023043635 countsByYear W20230436352020 @default.
• W2023043635 countsByYear W20230436352021 @default.
• W2023043635 countsByYear W20230436352022 @default.
• W2023043635 crossrefType "journal-article" @default.
• W2023043635 hasAuthorship W2023043635A5033038556 @default.
• W2023043635 hasAuthorship W2023043635A5070273099 @default.
• W2023043635 hasAuthorship W2023043635A5075273574 @default.
• W2023043635 hasAuthorship W2023043635A5084151540 @default.
• W2023043635 hasAuthorship W2023043635A5084968437 @default.
• W2023043635 hasBestOaLocation W20230436351 @default.
• W2023043635 hasConcept C118552586 @default.
• W2023043635 hasConcept C126322002 @default.
• W2023043635 hasConcept C127573956 @default.
• W2023043635 hasConcept C2775858608 @default.
• W2023043635 hasConcept C2777010014 @default.
• W2023043635 hasConcept C2777332695 @default.
• W2023043635 hasConcept C2778186239 @default.
• W2023043635 hasConcept C2778337148 @default.
• W2023043635 hasConcept C2778793413 @default.

• next